Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation
Abstract The comparative effectiveness of finerenone and spironolactone in chronic kidney disease (CKD) with type 2 diabetes (T2D) remains unclear. Here we show, using a target trial emulation on global real-world data from TriNetX, outcomes among 2268 propensity score–matched adults with CKD (eGFR...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Portfolio
2025-10-01
|
| Colección: | Nature Communications |
| Acceso en línea: | https://doi.org/10.1038/s41467-025-64640-3 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|